BioWorld MedTech

June 15, 2011

CerebralRx enters market with vagus nerve stimulation device

CerebralRx, a newly formed spin-off of BioControl Medical (both Yehud, Israel), is hitting the ground running with the launch of its FitNeS vagus nerve stimulation system for epilepsy in Europe. (Medical Device Daily) Read More

Washington roundup: FDA's new nanoscale materials guidance sets bar at 1,000 nm

International report: Medical Care Technologies expands Chinese operations

Device gives hospitals early sense of patient's condition

Financings roundup: UHS to offer $175M of second lien toggle notes

Med-Tech Notes

Agreements/contracts: pSivida amends glaucoma R&D development with Pfizer

HIT roundup: Premier releases PhysicianFocus for performance improvement

Patent watch: Biomoda expands use of assay with new patent

Grants roundup: Precision Medical receives QTDP grant for UI device

Product Briefs

People in the News

MDD's Oncology Extra

Today's news in brief

BioWorld

Illustration of SCAN in Parkinson’s vs healthy subcortex

SCAN is core circuit affected in Parkinson’s disease

BioWorld Science

Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...

TL1A is overexpressed in hidradenitis suppurativa

BioWorld Science

Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...

IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa

BioWorld Science

Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...

Astellas’ ASP-2246 shows promise in stroke management

BioWorld Science

Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...